Biotech Leader BeOne Medicines Eyes New Buy Point As Cancer Drug Sales Surge
Related news BREAKING: Two Big Space Stock Winners Deliver Earnings Investors.com will undergo scheduled maintenance from 10:00 PM ET to 2:00 AM ET and some features may be unavailable. We apologize for any inconvenience. Biotech leader BeOne Medicines (ONC) regained a key level in recent sessions and is approaching its latest buy point. That makes BeOne Tuesday's pick for IBD 50 Growth Stocks To Watch. BeOne Medicines is the new name for BeiGene, a biotech company founded in 2010 with employees in the U.S. ...